Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celvia
Tartu, Estoniacelvia.ee ↗
- Ownership
- Private
- Employees
- ~15
- Development stage
- Commercial
01
Overview
Celvia develops and commercializes CE-IVD validated in vitro diagnostic tests for reproductive medicine, including non-invasive prenatal testing (NIPT), endometrial health assessment, and microbiome analysis. Their NIPTIFY test is distributed across the European Union with ISO 15189 accreditation[5]. The company collaborates closely with academic institutions for research and data analysis.
- Therapeutic areas
- GastroenterologyWomen's Health
- Modalities
- In vitro diagnosticGenomic testing
- Industry
- Molecular Diagnostics
02
Partnerships
University of Tartu (data storage, genomic analysis)Collaborations with Estonian universities, biotechnology companies, scientific/medical/R&D institutions from Europe, Asia, America
Beyond the preview
Go deeper on Celvia.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Celvia.